Skip to main content
. 2018 Aug 21;46(4):473–481. doi: 10.1007/s11239-018-1724-0

Table 2.

Clinical outcomes within 3 months after MVr

Bleeding events Group A: VKA (N = 325) Group B: aspirin (N = 144)
Major bleeding 21 (6.8)a 14 (9.1)
 Site
  Chest 20 12
  GI tract 0 1
  Unknown 1 1
 Fatal bleeding 1 1
Thromboembolic events 8 (2.6) 2 (1.6)
 Type
  Ischemic stroke 4 1
  TIA 4 0
  Left atrial thrombus 0 1
 Fatal ischemic stroke 0 1

GI gastrointestinal, TIA transient ischemic attack, MI myocardial infarction, DVT deep venous thrombosis

aNumbers in parenthesis are cumulative incidence